We are live on ! Find out more
KERX

Keryx Biopharmaceuticals Inc
KERX

Delisted

KERX was delisted on the 12th of December, 2018.

Back to rankings

Fund managers haven’t disclosed any holdings of KERX yet.

KERX Hedge Fund Activity: Q1 2026 in Review

1 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q1 2026, worth a combined $3 — unchanged from a quarter earlier.

Fund positioning in KERX was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Keryx Biopharmaceuticals Inc (KERX) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $3 of Keryx Biopharmaceuticals Inc stock for Q1 2026, unchanged quarter-over-quarter.
  • 0 funds opened new Keryx Biopharmaceuticals Inc positions in Q1 2026 and 0 closed out.

Based on aggregated 13F filings for Q1 2026.